European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

European equities traded in the US as American depositary receipts were tracking slightly lower late Thursday morning, declining 0.04% to 1,402.70 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma (ASND) and biotech company BioNTech (BNTX), which climbed 14.9% and 6.3% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and biotech company and Evaxion Biotech (EVAX), which rose 5.6% and 1.5% respectively.

The decliners from continental Europe were led by consumer goods company Unilever (UL) and pharmaceutical company Novo Nordisk (NVO), which fell 5% and 3% respectively. They were followed by telecommunications company Nokia (NOK) and financial services company Banco Santander (SAN), which were off 0.5% each.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin (AMRN) and pharmaceutical company Silence Therapeutics (SLN), which increased 6.7% and 3.3% respectively. They were followed by alcoholic beverage company Diageo (DEO) and biopharmaceutical company NuCana (NCNA), which were up 2.6% and 2.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and tobacco company British American Tobacco (BTI), which shed 16.3% and 9.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and financial services company Barclays (BCS), which were down 6.7% and 4.8% respectively.